Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus
- PMID: 16820145
- DOI: 10.1016/j.cca.2006.05.018
Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus
Abstract
Background: Lipoprotein (a) [Lp(a)] is known to be a risk factor for atherosclerotic disease. However, the relationship between Lp(a) and arterial stiffness has not been clarified. We investigated whether atherosclerotic risk factors, including serum Lp(a), are associated with aortic stiffness in elderly patients with type 2 diabetes mellitus.
Methods: Aortic stiffness, evaluated by using aortic pulse wave velocity, and major atherosclerotic risk factors were measured in elderly (> or =65 years) patients with type 2 diabetes mellitus. Relationships between aortic pulse wave velocity, Lp(a) and other atherosclerotic risk factors were analyzed.
Results: Among the atherosclerotic risk factors measured, age, pulse pressure, hemoglobin A1c (HbA1c), uric acid, fibrinogen, sialic acid and Lp(a) showed significant positive correlations with aortic pulse wave velocity. Lp(a) also showed significant positive correlations with pulse pressure, fibrinogen, sialic acid, apolipoprotein B and apolipoprotein B/apolipoprotein A-I ratio. The correlation between Lp(a) and aortic pulse wave velocity was independent of age, sex, blood hemoglobin A1c, uric acid and fibrinogen, history of diabetic nephropathy and therapy with lipid-lowering drugs. Apolipoprotein A-II showed a significant negative correlation with both aortic pulse wave velocity and Lp(a). The median level of Lp(a) in the highest tertile group of subjects divided by aortic pulse wave velocity was significantly higher than the median Lp(a) level in the lowest tertile. The middle and highest tertile groups of subjects divided by aortic pulse wave velocity showed significantly high odds ratios of high Lp(a) levels (> or =30 mg/dl) vs the lowest tertile.
Conclusions: Lp(a) is an independent determinant of aortic stiffness in elderly patients with type 2 diabetes mellitus.
Similar articles
-
Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus.Clin Chim Acta. 2006 Mar;365(1-2):230-5. doi: 10.1016/j.cca.2005.08.023. Epub 2005 Sep 29. Clin Chim Acta. 2006. PMID: 16199026
-
Association of pulse pressure with carotid atherosclerosis in patients with type 2 diabetes mellitus.Blood Press. 2007;16(1):56-62. doi: 10.1080/08037050701248051. Blood Press. 2007. PMID: 17453753
-
Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.Thromb Res. 2007;121(1):95-102. doi: 10.1016/j.thromres.2007.02.014. Epub 2007 Apr 17. Thromb Res. 2007. PMID: 17439823
-
[Lipoprotein (a)--a mysterious factor in atherogenesis].Lijec Vjesn. 2002 Nov-Dec;124(11-12):366-71. Lijec Vjesn. 2002. PMID: 12679978 Review. Croatian.
-
The relationship between lipoprotein(a) and the complications of diabetes mellitus.Acta Diabetol. 2003 Jun;40(2):65-76. doi: 10.1007/s005920300007. Acta Diabetol. 2003. PMID: 12861403 Review.
Cited by
-
Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China.J Atheroscler Thromb. 2025 Apr 1;32(4):513-524. doi: 10.5551/jat.65214. Epub 2024 Oct 22. J Atheroscler Thromb. 2025. PMID: 39443133 Free PMC article.
-
Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.J Endocrinol Invest. 2014 May;37(5):441-7. doi: 10.1007/s40618-013-0034-9. Epub 2014 Jan 9. J Endocrinol Invest. 2014. PMID: 24682912
-
Serum Lipoprotein(a) Levels as a Predictor of Aortic Stiffness in Patients on Long-Term Peritoneal Dialysis.Med Sci Monit. 2024 Jun 5;30:e944348. doi: 10.12659/MSM.944348. Med Sci Monit. 2024. PMID: 38835156 Free PMC article.
-
Lipoprotein(a) Levels and Adverse Outcomes in Heart Failure.J Card Fail. 2025 Apr 4:S1071-9164(25)00160-5. doi: 10.1016/j.cardfail.2025.03.016. Online ahead of print. J Card Fail. 2025. PMID: 40189094
-
Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levels.Atheroscler Plus. 2022 Aug 2;50:1-9. doi: 10.1016/j.athplu.2022.07.001. eCollection 2022 Dec. Atheroscler Plus. 2022. PMID: 36643800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous